Company

Genlight Neurotech

佳量医疗

Genlight Neurotech (佳量医疗) is a Chinese medtech company in Qiming Venture Partners' portfolio, focused on neurosurgical and brain-related technologies. As of mid-2025, it was preparing to launch its LaserRO™ next-generation MRI-guided laser ablation minimally invasive surgery system, which it showcased at the 8th Academic Annual Meeting of the CAAE Stereotactic Electroencephalography and Brain Mapping Committee . The company has also been recognized in industry rankings, including being named among the top 50 most influential healthcare enterprises by enterprise lists in 2025 . Beyond its core surgical systems, Genlight has positioned itself within the broader AI and neurotechnology space, appearing alongside other Qiming portfolio companies at the 2025 World Artificial Intelligence Conference .

elsewhere's corpus does not cover Genlight's founding date, funding history, or full product pipeline beyond these portfolio updates from Qiming Venture Partners.

AI-generated — may contain errors, please verify.

Genlight NeurotechCompany
佳量医疗
渲染中…
Mentioned in 7 articles

Coverage